Judges

ASIC has won its case alleging Regional Express failed to correct an optimistic forecast before it entered administration last year, but failed to prove the company's optimism conveyed a "likelihood" or that three non-executive directors had actual knowledge of the collapsed budget airline's declining business. 

A judge has ordered soft class closure in a class action by Queensland police officers and staff over the COVID-19 vaccine, forcing group members to register for the case ahead of settlement talks.

A judge has found that ASIC's case against WA gold mining company Wiluna over alleged omissions in a 2022 ASX announcement should await the determination of related cases against two executives, citing the risk of inconsistent findings. 

A judge has been asked to approve a revised $18.1 million settlement in an underpayments class action against Sydney Trains, reached after the registration of 260 new group members pushed the settlement above the agreed cap.

US drug maker Cosette wants to strike out Mayne Pharma's causation pleading in its suit seeking damages after Cosette allegedly inducing the treasurer to reject their $672 million tie-up.

Clothing giant H&M has been hit with a costs order after a judge found it was unreasonable for it to maintain a suppression application in a Fair Work case brought by its former head of human resources in Australia.

A judge will hear an application to amend by the applicants in two discrimination cases against University of Sydney academics accused of making allegedly antisemitic statements, saying the issues in the pleading had to be ruled on.

An activist group can't block the owners of Claravale Station from clearing almost 3,000 hectares of savanna in the Northern Territory, with a judge finding it would be difficult to prove the government’s decision was legally unreasonable.

A recycling company has lost its bid to recover millions of dollars from its insurers, with a judge finding the insurers were not on the hook for losses arising from an EPA cleanup.

A class action against Johnson & Johnson over alleged ineffective cold medicine has attacked the pharmaceutical company’s application for soft class closure, telling a court the process would produce useless data and only need to be repeated.